Safe Rx announces availability in AmerisourceBergen
Safe Rx announced its product availability in AmerisourceBergen, with merchandising kits available to all AmerisourceBergen California customers.
Pharmacy
Cardinal Health acquires Mirixa Corp.
Cardinal Health announced today it has acquired Mirixa Corp., a leading provider of technology-enabled solutions for the provision of medication therapy management (MTM) services, from the National Community Pharmacists Association (NCPA).
Cost, safety main reasons for personal prescription imports from Canada
The Campaign for Personal Prescription Importation (CPPI) today released survey results highlighting the reasons Americans continue to purchase their personal prescriptions from licensed and legitimate online pharmacies in Canada, safely, at considerable cost savings, and often at the recommendation
Lilly to acquire Loxo Oncology
Eli Lilly and Co. and Loxo Oncology, Inc. today announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash, or approximately $8.0 billion.
Cardinal Health Foundation supports new initiatives for the OHA
As part of its long-standing commitment to reduce opioid misuse and abuse, the Cardinal Health Foundation is pleased to announce a $530,000 grant to the Ohio Hospital Association (OHA) to identify and deploy best opioid prescribing practices for pain management among OHA member hospitals across the
Diplomat partners with CSI Specialty Group to expand health system services
Diplomat Pharmacy and CSI Specialty Group, a globally recognized specialty pharmacy consulting firm, have launched a program for hospitals and health systems interested in starting or expanding their own specialty pharmacy services to benefit from Diplomat’s limited-distribution drug portfolio and e
Branded prescription drug spend — A basic framework
Drug prices are a major target of patient groups and Congress, although drug spending makes up only 10% of the $3.3 trillion spent on U.S. health care in a year.
Diplomat provides updated 2018 guidance and preliminary 2019 outlook
Diplomat Pharmacy is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in San Francisco. Diplomat now expects 2018 revenue to be at the lower end of the previously communicated $5.5 to $5.
MinuteClinic opens walk-in medical clinic in Dallas, Pa.
WOONSOCKET, RI – A new MinuteClinic walk-in medical clinic has opened inside the CVS Pharmacy store at 5 Church Street in Dallas, Pa., providing the community with convenient access to common health care services. The clinic will be open Monday through Friday with no appointment necessary.
Hy-Vee offers controlled substance prescription policy
To assist in combatting the national opioid epidemic Hy-Vee announces the implementation of a new controlled substance prescription policy. As of Jan.
Bristol-Myers Squibb to Acquire Celgene Corporation
In a deal worth $74 billion, Bristol-Myers Squibb announced today its plans to acquire Celgene Corporation.
Prices boosted on hundreds of drugs
Drugmakers are increasing the price of hundreds of drugs by an average of more than 6%, according to a new analysis by Rx Savings Solutions. With pressure on the pharmaceutical industry to hold down prices mounting, many of the increases are relatively small.
Healthwarehouse.com reaps benefits of Innovation’s high-volume mail order pharmacy automation
Six months after replacing after replacing prior automation with Innovation’s PharmASSIST high-volume Quick Start prescription fulfillment system, mail order pharmacy HealthWarehouse.com is touting dramatic improvements in operational efficiency. Healthwarehouse.
Dr. Reddy’s launches sevelamer carbonate for oral suspension in U.S.
Dr. Reddy’s Laboratories announced the launch of sevelamer carbonate for oral suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for oral suspension, approved by the U.S. Food and Drug Administration. The Renvela brand and generic had U.
Dr. Reddy’s rolls out aspirin and extended-release dipyridamole capsules
Dr. Reddy’s Laboratories Ltd. recently announced the launch of aspirin and extended-release dipyridamole capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) capsules in the United States market from the U.S. Food and Drug Administration.
Cigna completes Express Scripts deal
Cigna Corp. has successfully completed its combination with Express Scripts Holding Company effective December 20, 2018.